FIELD: medicine.
SUBSTANCE: invention relates to a method of treating acute myeloid leukaemia. A method of treating acute myeloid leukaemia in a subject in need thereof comprises administering to the subject an effective amount of 5-fluoro-2-(6-fluoro-2-methyl-1H-benzo[ d ]imidazol-1-yl)-N4-[4-(trifluoromethyl)phenyl]pyrimidine-4,6-diamine, the structure of which is represented by formula (I):
Formula (I)
or a pharmaceutically acceptable salt thereof or a pharmaceutical composition thereof, wherein the effective amount reaches an average plasma concentration over 24 hours of 3 hours*mcg/ml to 70 hours*mcg/ml.
EFFECT: above invention makes it possible to treat acute myeloid leukemia in a subject in need thereof by injecting to the subject an effective amount of a compound represented by formula (I).
10 cl, 6 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CYTARABINE CONJUGATES FOR TREATING CANCER | 2016 |
|
RU2708672C1 |
| PHORBOL ESTER COMPOSITIONS AND METHODS OF USING THEM FOR TREATING OR REDUCING DURATION OF CYTOPENIA | 2015 |
|
RU2730998C2 |
| CONJUGATE SALTS FOR CANCER TREATMENT | 2016 |
|
RU2747528C2 |
| PHARMACEUTICAL COMPOUND | 2018 |
|
RU2786994C2 |
| METHODS OF TREATING LEUKOPENIA AND THROMBOCYTOPENIA | 2015 |
|
RU2702122C2 |
| NOVEL APPROACH TO CANCER TREATMENT USING IMMUNOMODULATION | 2016 |
|
RU2817047C2 |
| SOLID FORMS OF THE COMPOUND MODULATING THE KINASES | 2016 |
|
RU2730506C2 |
| USE OF COMPOUNDS IN TREATING FUNGAL INFECTIONS | 2021 |
|
RU2805930C1 |
| METHODS OF TREATING DISEASES AND DISORDERS ASSOCIATED WITH LSD1, LSD1 INHIBITORS | 2020 |
|
RU2826217C1 |
| COMBINATION OF OZOGAMICIN INOTUZUMAB AND TORIZEL FOR TREATING CANCER | 2012 |
|
RU2607594C2 |
